Yu Kaku a, Kaho Okumura b, Shusuke Kawakubo a, Keiya Uriu a, Luo Chen a, c, Yusuke Kosugi a, d, Yoshifumi Uwamino e, MST Monira Begum f, Sharee Leong f, Terumasa Ikeda f, Kenji Sadamasu h, Hiroyuki Asakura h, Mami Nagashima h, Kazuhisa Yoshimura h, The Genotype to Phenotype Japan (G2P-Japan) Consortium
Jumpei Ito
a, i, Kei Sato
a, c, d, g, i, j, k a Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
b Faculty of Liberal Arts, Sophia University, Tokyo, Japan
c Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan
d Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
e Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan
f Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan
g Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan
h Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
i International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
j International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
k MRC–University of Glasgow Centre for Virus Research, Glasgow, UK